Tag: B-cell lymphoma

AZ, Forty Seven to test triple immunotherapy combo for lymphoma

by Anna Smith | May 13, 2019 | News | 0

5F9 will be tested in combination with rituximab and Calquence (acalabrutinib) for diffuse large B-cell lymphoma.

US approves second CAR-T therapy

by Selina McKee | Oct 19, 2017 | News | 0

Gilead’s Yescarta – recently acquired through its purchase of Kite Pharma – has become the second gene therapy to be approved by the US Food and Drug Administration, offering a new treatment approach for patients with certain types of large B-cell lymphoma.

Novartis’ CAR-T shows durable response in lymphoma patients

by Selina McKee | Jun 8, 2017 | News | 0

Novartis’ closely-watched CTL019 has elicited a strong response in cancer patients taking the experimental CAR-T cell therapy in a mid-stage trial.

Roche’s Gazyva fails to hit target in lymphoma trial

by Selina McKee | Jul 19, 2016 | News | 0

Roche’s new blood cancer drug Gazyva has failed to show significant improvements versus veteran therapy MabThera/Rituxan in patients with previously untreated diffuse large B-cell lymphoma, marking a setback in plans to protect sales from biosimilar competition.